Royalty Pharma plc
RPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,331 | $1,700 | $230 | $1,241 |
| Dep. & Amort. | $0 | $0 | $6 | $23 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $2 | $2 |
| Change in WC | $53 | $5 | $33 | -$16 |
| Other Non-Cash | $1,382 | $1,280 | $1,873 | $767 |
| Operating Cash Flow | $2,769 | $2,988 | $2,144 | $2,018 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | -$11 | -$13 | -$10 | -$35 |
| Inv. Purchases | -$2,736 | -$2,116 | -$2,565 | -$3,594 |
| Inv. Sales/Matur. | $118 | $26 | $1,546 | $1,776 |
| Other Inv. Act. | -$49 | $29 | $0 | -$18 |
| Investing Cash Flow | -$2,678 | -$2,073 | -$1,029 | -$1,870 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,471 | -$1,000 | $0 | $1,273 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$230 | -$305 | $0 | $0 |
| Dividends Paid | -$376 | -$358 | -$333 | -$285 |
| Other Fin. Act. | -$504 | -$486 | -$612 | -$602 |
| Financing Cash Flow | $361 | -$2,149 | -$945 | $385 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $452 | -$1,234 | $170 | $532 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $477 | $1,711 | $1,541 | $1,009 |
| End Cash | $929 | $477 | $1,711 | $1,541 |
| Free Cash Flow | $2,769 | $2,988 | $2,144 | $2,018 |